Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Banxia Tianma Wan for peripheral vertigo
ChiCTR2300078232Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Ban Xia Bai Zhu Tian Ma Tang in Peripheral vertigo, benign paroxysmal positional vertigo (BPPV), Meniere Disease and 1 more (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Total effective rate. Started Dec 2023; status: recruiting.
02
Drugs
Ban Xia Bai Zhu Tian Ma Tang
03
Conditions
Peripheral vertigobenign paroxysmal positional vertigo (BPPV)Meniere Diseasevestibular neuritis
Beyond the preview
Go deeper on ChiCTR2300078232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078232.